Related Experiment Video
Updated: Jun 30, 2026

Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
Gastroesophageal reflux in children
1Div. of Pediatric Gastroenterology, Academic Children's Hospital, Free University of Brussels, Belgium.
Insights
Gastroesophageal reflux in infants is common but can be serious. Prokinetic agents offer an effective, safe treatment option for pediatric reflux disease by addressing underlying motility issues.
Area of Science:
- Pediatric Gastroenterology
- Neonatal Medicine
- Pharmacology
Background:
- Gastroesophageal reflux (GER) is highly prevalent in infants, often considered physiological.
- However, infant GER can lead to significant morbidity and mortality.
- Optimal management requires balancing under-treatment and over-intervention.
Purpose of the Study:
- To determine the most effective and safest treatment approach for reflux in children.
- To advocate for investigations limited to a minimum.
- To identify treatments with minimal side effects.
Main Methods:
- Focus on the pathophysiological mechanism of reflux disease in children.
- Evaluation of prokinetic agents as a treatment modality.
- Assessment of the side effect profile of prokinetic agents.
Main Results:
- The primary pathophysiological mechanism in pediatric reflux disease is a motility disorder.
- Prokinetic agents are indicated for treating this condition.
- Prokinetic agents demonstrate a very low incidence of side effects.
Conclusions:
- Prokinetic agents are a suitable treatment for pediatric reflux disease.
- Their efficacy and favorable safety profile make them advantageous for treating infant reflux.
- This approach avoids over-investigation and over-treatment.
Abstract:
Gastroesophageal reflux is so common in infancy that the phenomenon is usually considered to be physiologic. However, reflux in infants has also been related to severe morbidity and even death. The art of selecting the optimal approach to treating reflux in children is to avoid over-investigations and over-treatment as well as the other extreme of neglecting the problem. Therefore investigations should be limited to a minimum and the treatment chosen should be effective but at the same time as free of side effects as possible. Since the basic pathophysiologic mechanism of reflux disease in children is a motility problem, prokinetic agents are indicated for the treatment of this condition. The very low incidence of side effects with these agents is also a relevant advantage to their use in the treatment of pediatric reflux disease.
Related Concept Videos
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Achalasia
Gastroesophageal Reflux Disease

